showed that mutations in NOTCH1, SF3B1, TP53 and XPO1 genes were already present at the level of CD34+ multipotent hematopoietic progenitors in the majority of patients with CLL (243). This evidence concerns the gene CD34 and B-cell chronic lymphocytic leukemia.